Assembly Biosciences, Inc.
ASMB
$26.93
$0.281.05%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 74.98M | 91.03M | 112.08M | 94.95M | 109.22M |
| Total Receivables | 300.00K | 400.00K | 400.00K | 400.00K | 400.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.19M | 4.10M | 3.02M | 2.86M | 3.31M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 77.47M | 95.53M | 115.50M | 98.21M | 112.93M |
|
|
|||||
| Total Current Assets | 77.47M | 95.53M | 115.50M | 98.21M | 112.93M |
| Net Property, Plant & Equipment | 3.00M | 3.18M | 3.35M | 1.74M | 2.08M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 312.00K | 312.00K | 312.00K | 312.00K | 312.00K |
| Total Assets | 80.78M | 99.02M | 119.17M | 100.26M | 115.32M |
|
|
|||||
| Total Accounts Payable | 743.00K | 875.00K | 585.00K | 1.34M | 801.00K |
| Total Accrued Expenses | 5.10M | 4.41M | 9.14M | 6.35M | 6.12M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 533.00K | 529.00K | 461.00K | 1.33M | 1.30M |
| Total Finance Division Other Current Liabilities | 40.92M | 40.82M | 37.62M | 32.62M | 33.06M |
| Total Other Current Liabilities | 40.92M | 40.82M | 37.62M | 32.62M | 33.06M |
| Total Current Liabilities | 47.29M | 46.63M | 47.80M | 41.64M | 41.27M |
|
|
|||||
| Total Current Liabilities | 47.29M | 46.63M | 47.80M | 41.64M | 41.27M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.35M | 2.49M | 2.63M | 113.00K | 451.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 13.04M | 22.76M | 35.38M | 32.51M | 38.92M |
| Total Liabilities | 62.68M | 71.88M | 85.81M | 74.26M | 80.64M |
|
|
|||||
| Common Stock & APIC | 863.32M | 862.13M | 859.50M | 841.75M | 840.95M |
| Retained Earnings | -844.94M | -834.74M | -825.93M | -815.59M | -805.98M |
| Treasury Stock & Other | -279.00K | -253.00K | -211.00K | -156.00K | -293.00K |
| Total Common Equity | 18.10M | 27.13M | 33.36M | 26.00M | 34.68M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 18.10M | 27.13M | 33.36M | 26.00M | 34.68M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 18.10M | 27.13M | 33.36M | 26.00M | 34.68M |
|
|
|||||